What is Esperion Therapeutics Inc.’s (NASDAQ:ESPR) current market value? Can you beat the fundamentals?
In yesterday’s Wall Street session, Esperion Therapeutics Inc. (NASDAQ:ESPR) shares traded at $1.63, up 3.16% from the previous session. 9 analysts cover Esperion Therapeutics Inc. (NASDAQ:ESPR), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and a […]
There’s Something Awry at Esperion Therapeutics Inc. (NASDAQ:ESPR) Since Share Price Gets Ahead of Fundamentals
The stock of Esperion Therapeutics Inc. (NASDAQ:ESPR) last traded at $1.44, down -5.88% from the previous session. Data from the available sources indicates that Esperion Therapeutics Inc. (NASDAQ:ESPR) is covered by 9 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of […]
Esperion Therapeutics Inc. (ESPR) – Mismatched value: Check Out the Fundamental Analysis
Stocks of Esperion Therapeutics Inc. (NASDAQ:ESPR) traded higher last session on Wall Street, down -1.85% to $1.59. According to the data, Esperion Therapeutics Inc. (NASDAQ:ESPR) has 9 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and […]
Does Esperion Therapeutics Inc. (NASDAQ:ESPR) presents a BIG investment opportunity?
Stocks of Esperion Therapeutics Inc. (NASDAQ:ESPR) traded higher last session on Wall Street, up 10.07% to $1.53. According to the data, Esperion Therapeutics Inc. (NASDAQ:ESPR) has 9 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $22.00 and […]
Can Esperion Therapeutics Inc. (ESPR) stock recover despite sales dropping?
The price of Esperion Therapeutics Inc. (NASDAQ:ESPR) shares last traded on Wall Street rose 9.86% to $1.56. Based on available information, 9 analysts follow Esperion Therapeutics Inc. (NASDAQ:ESPR). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $22.00 and a low of […]
